Journal on oncology (ISSN 2692-563X)

Journal on oncology
ISSN 2692-563X
Impact Factor: 1.3

Journal on oncology publishes relevant and up-to-date open access journals in the fields of experimental and clinical oncology research.

How important is early Disease Detection through Regular Systematic Examinations in People older than 65 Years: An Example of Two Cases

Ana Miljković

Role of Androgen Receptor in Prostate Cancer: A Brief Update

Mohammed Akhtar; Khaled A Murshed*; Noheir M Taha; Hussam Telfah; Issam Al Bozom

Why Choose Us?

Open Access

Open access publications are freely and permanently available online to anyone with an internet connection.

Quick Review Process

Journal on oncology (ISSN 2692-563X) follows a quick peer-review process and a rapid publication of the articles.

Our Guidelines

They are guidelines that should be followed by authors, reviewers and editors to maintain the journal integrity.

Latest Articles

Biological Memory of the Genome: An Extension of the Gene Latency Framework

Research Article Open Access

The sequencing of complex genomes has fundamentally transformed modern biology by providing unprecedented insight into the genetic architecture of living systems. The completion of the Human Genome Project revealed that the human genome contains approximately three billion base pairs of DNAS yet encodes only around twenty thousand protein-coding genes [1,2]. This discovery challenged earlier ..

PDF
HTML

Survival Outcomes of Systemic Therapy in Advanced and Metastatic Pancreatic Adenocarcinoma: A Single-Center Retrospective Study

Research Article Open Access

Pancreatic Ductal Adenocarcinoma (PDAC) remains one of the most lethal malignancies worldwide, typically characterized by late-stage diagnosis and poor long-term prognosis [1]. For the vast majority of patients presenting with locally advanced or distant metastatic disease, systemic chemotherapy serves ..

PDF
HTML

Berberine Abrogates Paclitaxel-Induced Tumor Repopulation and M2 Macrophage Polarization in Ovarian Cancer by Disrupting the COX-2 Signaling Axes

Research Article Open Access

Ovarian cancer remains one of the most lethal gynecological malignancies worldwide, characterized by late-stage diagnosis and a high mortality rate [1]. Currently, Paclitaxel (PTX)-based chemotherapy is the frontline treatment for advanced ovarian cancer. Despite achieving significant initial tumor regression, a vast majority of patients eventually experience ..

PDF
HTML

Prognostic and Immunological Role of CNIH1 in Cervical Cancer: A Pan-Cancer Analysis

Research Article Open Access

Cancer poses a serious threat to global public health, with both its incidence and mortality rates continuing to rise annually [1]. Among the most common and lethal cancers worldwide are lung, pancreatic, and liver cancers [1]. Although significant advancements have been made ..

PDF
HTML

Consistency Analysis of Genomic Alterations Between Tumor Tissue and Circulating Cell-Free DNA in Untreated Lung Adenocarcinoma in Southern Jiangsu Region of China

Research Article Open Access

With the increasing mortality, lung adenocarcinoma has become the most common cancer and the leading cause of cancer-related death in China [1]. According to histology type, over 85% lung adenocarcinoma patients were classified into Non-Small Cell Lung Cancer (NSCLC). And more than 70% of them were in advanced stage when firstly diagnosed, and then accompanied ..

PDF
HTML

About Our Journal

The Journal publishes original research articles related to oncology, our journal covers articles related to all types on cancers and make sure that the published articles should be available online for the researchers and medical practisers.

We are maintaining a highest level of reviews whether it is peer to peer or editorial review process. Our most important factor in publishing the journals is the quality or impact on the researchers. We try to put as many as reviewers such that the manuscript submitted should be reviewed from many different angels and editors comments are always forward back to the submitter such that can rework into it where it is necessary. Our goal is to publish articles which can really help the researchers.